{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:08:54Z","timestamp":1772014134575,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.heliyon.2022.e10101","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000}}],"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.heliyon.2022.e10101","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T18:38:27Z","timestamp":1659983907000},"page":"e10101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["RETRACTED: In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-6245","authenticated-orcid":false,"given":"Mustapha","family":"Abdullahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adamu","family":"Uzairu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon Adamu","family":"Shallangwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Mamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Tukur","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2022.e10101_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1574892812666170508125927","article-title":"3D-QSAR (CoMFA, CoMSIA) and molecular docking studies on histone deacetylase 1 selective inhibitors","volume":"12","author":"Abdizadeh","year":"2017","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42269-020-00389-7","article-title":"Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents","volume":"44","author":"Abdullahi","year":"2020","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.heliyon.2022.e10101_bib3","article-title":"In-silico design and ADMET predictions of some new imidazo [1, 2-a] pyridine-3-carboxamides (IPAs) as anti-tubercular agents","volume":"25","author":"Abdullahi","year":"2021","journal-title":"J.\u00a0Clin. Tuberc. Other Mycobact. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib4","first-page":"1","article-title":"In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype","volume":"9","author":"Abdullahi","year":"2020","journal-title":"J.\u00a0Basic Appl. Sci."},{"key":"10.1016\/j.heliyon.2022.e10101_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2016.05.006","article-title":"The E119D\u00a0neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models","volume":"132","author":"Abed","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2022.e10101_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104539","article-title":"Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitors","volume":"169","author":"Adams","year":"2019","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10101_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.56499\/jppres22.1345.10.4.571","article-title":"In silico ADME-T and molecular docking study of phytoconstituents from Tithonia diversifolia (Hemsl.) A. Gray on various targets of diabetic nephropathy","volume":"10","author":"Adianingsih","year":"2022","journal-title":"J.\u00a0Pharm. Pharmacogn. Res."},{"key":"10.1016\/j.heliyon.2022.e10101_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.compbiolchem.2018.12.017","article-title":"2\/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives","volume":"78","author":"Ahamad","year":"2019","journal-title":"Comput. Biol. Chem."},{"issue":"19","key":"10.1016\/j.heliyon.2022.e10101_bib9","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1039\/D1RA09318E","article-title":"Novel adamantyl clubbed iminothiazolidinones as promising elastase inhibitors: design, synthesis, molecular docking, ADMET and DFT studies","volume":"12","author":"Ahmed","year":"2022","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/14756366.2020.1861606","article-title":"Novel piperazine\u2013chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation","volume":"36","author":"Ahmed","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e10101_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053768","article-title":"SARS-CoV-2 and influenza virus coinfection among patients with severe acute respiratory infection during the first wave of COVID-19 pandemic in Bangladesh: a hospital-based descriptive study","volume":"11","author":"Akhtar","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e10101_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2174\/1573409915666190918150136","article-title":"2D- and 3D-QSAR modeling of imidazole-based glutaminyl cyclase inhibitors","volume":"16","author":"Al-Attraqchi","year":"2020","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.heliyon.2022.e10101_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101495","article-title":"T\u00a0helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: from cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.heliyon.2022.e10101_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7715689","article-title":"Cytotoxic evaluation, molecular docking, and 2D-QSAR studies of dihydropyrimidinone derivatives as potential anticancer agents","author":"Altaf","year":"2022","journal-title":"J.\u00a0Oncology"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40203-018-0043-7","article-title":"Computer aided drug design based on 3D-QSAR and molecular docking studies of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives as PIM2 inhibitors: a proposal to chemists","volume":"6","author":"Aouidate","year":"2018","journal-title":"Silico Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10101_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030404","article-title":"2D-QSAR and 3D-QSAR\/CoMSIA studies on a series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with human beta(3)-adrenergic activity","volume":"22","author":"Apablaza","year":"2017","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.heliyon.2022.e10101_bib17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/foods11111576","article-title":"Prediction of ACE-I inhibitory peptides derived\u00a0from chickpea (cicer arietinum L.): in silico assessments using simulated enzymatic hydrolysis, molecular docking and ADMET evaluation","volume":"11","author":"Ar\u00e1mburo-G\u00e1lvez","year":"2022","journal-title":"Foods"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10101_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2020.04.011","article-title":"Influenza A H1N1 virus 2009 synthetic hemagglutinin and neuraminidase peptides for antibody detection","volume":"51","author":"Avila","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-10253-5","article-title":"Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach","volume":"12","author":"Aziz","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2022.e10101_bib20","series-title":"Structure-based Discovery of Multitarget Directed Anti-inflammatory P-Nitrophenyl Hydrazones; Molecular Docking, Drug-Likeness, In-Silico Pharmacokinetics, and Toxicity Studies","author":"Babalola","year":"2022"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10101_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"issue":"7-8","key":"10.1016\/j.heliyon.2022.e10101_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2298\/JSC200618066B","article-title":"Use of GA-ANN and GA-SVM for a QSPR study on the aqueous solubility of pesticides","volume":"86","author":"Bouakkadia","year":"2021","journal-title":"J.\u00a0Serb. Chem. Soc."},{"key":"10.1016\/j.heliyon.2022.e10101_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejmech.2014.03.069","article-title":"Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis","volume":"78","author":"Chauhan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2022.e10101_bib24","doi-asserted-by":"crossref","first-page":"S600","DOI":"10.1016\/j.arabjc.2012.10.021","article-title":"QSAR models for prediction study of HIV protease inhibitors using support vector machines, neural networks and multiple linear regression","volume":"10","author":"Darnag","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.heliyon.2022.e10101_bib25","series-title":"Delivery of RNA Therapeutics: the Great Endosomal Escape! Nucleic Acid Therapeutics","author":"Dowdy","year":"2022"},{"key":"10.1016\/j.heliyon.2022.e10101_bib26","article-title":"3D-QSAR study of the chalcone derivatives as anticancer agents","author":"ElMchichi","year":"2020","journal-title":"J.\u00a0Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e10101_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4155\/fmc-2019-0256","article-title":"New pharmacological findings linked to biphenyl DHPMs, kinesin Eg5 ligands: anticancer and antioxidant effects","volume":"12","author":"Gon\u00e7alves","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.heliyon.2022.e10101_bib28","first-page":"1","article-title":"3D-QSAR modeling and molecular docking studies on a series of 2, 4, 5-trisubstituted imidazole derivatives as CK2 inhibitors","author":"Goudzal","year":"2022","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/07391102.2019.1705185","article-title":"Computational investigation of imidazopyridine analogs as protein kinase B (Akt 1) allosteric inhibitors by using 3D-QSAR, molecular docking and molecular dynamics simulations","volume":"39","author":"Gu","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10101_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/cid\/ciab625","article-title":"Reducing influenza virus transmission: the potential value of antiviral treatment","volume":"74","author":"Hayden","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e10101_bib31","series-title":"Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics of Biological Products, Biologics and Biosimilars","first-page":"121","author":"Hossen","year":"2022"},{"key":"10.1016\/j.heliyon.2022.e10101_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.sciaf.2020.e00503","article-title":"Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach","volume":"9","author":"Ibrahim","year":"2020","journal-title":"Scientif. African"},{"key":"10.1016\/j.heliyon.2022.e10101_bib33","series-title":"Silico Methods for Predicting Drug Toxicity","first-page":"85","article-title":"Silico Tools and Software to Predict ADMET of New Drug Candidates","author":"Kar","year":"2022"},{"key":"10.1016\/j.heliyon.2022.e10101_bib34","article-title":"World health organization influenza-like illness underestimates the burden of respiratory syncytial virus infection in community-dwelling older adults","author":"Korsten","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10101_bib35","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.3390\/ijms13044496","article-title":"Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus","volume":"13","author":"Lu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10101_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ardp.201500342","article-title":"Discovery of novel pyrazole derivatives as potent neuraminidase inhibitors against influenza H1N1 virus","volume":"349","author":"Meng","year":"2016","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12010-021-03718-2","article-title":"Screening and identification of potential iNOS inhibitors to curtail cervical cancer progression: an in silico drug repurposing approach","volume":"194","author":"Poleboyina","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.heliyon.2022.e10101_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chemolab.2016.01.008","article-title":"Be aware of error measures. Further studies\u00a0on validation of predictive QSAR models","volume":"152","author":"Roy","year":"2016","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.heliyon.2022.e10101_bib39","series-title":"A\u00a0Primer on QSAR\/QSPR Modeling: Fundamental Concepts","author":"Roy","year":"2015"},{"key":"10.1016\/j.heliyon.2022.e10101_bib40","series-title":"Statistical Methods in QSAR\/QSPR, A Primer on QSAR\/QSPR Modeling","first-page":"37","author":"Roy","year":"2015"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10101_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/1062936X.2019.1588159","article-title":"QSAR modelling on a series of arylsulfonamide-based hydroxamates as potent MMP-2 inhibitors","volume":"30","author":"Sanyal","year":"2019","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.heliyon.2022.e10101_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2019.100284","article-title":"Computational analysis of drug like candidates against Neuraminidase of Human Influenza A virus subtypes","volume":"18","author":"Selvaraj","year":"2020","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.heliyon.2022.e10101_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6380336","article-title":"3D-QSAR studies of 1,2,4-oxadiazole derivatives as sortase A inhibitors","volume":"2021","author":"Shakour","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2022.e10101_bib44","first-page":"1","article-title":"In silico design of novel FAK inhibitors using integrated molecular docking, 3D-QSAR and molecular dynamics simulation studies","author":"Shirvani","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10101_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/01973533.2016.1277529","article-title":"Extracting the variance inflation factor and other multicollinearity diagnostics from typical regression results","volume":"39","author":"Thompson","year":"2017","journal-title":"Basic Appl. Soc. Psychol."},{"issue":"6-7","key":"10.1016\/j.heliyon.2022.e10101_bib46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inform."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10101_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13721-019-0202-8","article-title":"QSAR modeling for the prediction of pGI 50 activity of compounds on LOX IMVI cell line and ligand-based design of potent compounds using in silico virtual screening","volume":"8","author":"Umar","year":"2019","journal-title":"Netw. Model. Anal. Health Inform. Bioinform."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e10101_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002249","article-title":"Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition","volume":"7","author":"Vavricka","year":"2011","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10101_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00894-020-04648-2","article-title":"Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques","volume":"27","author":"Vishwakarma","year":"2021","journal-title":"J.\u00a0Mol. Model."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e10101_bib50","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.2174\/0929867324666170712115411","article-title":"Rational drug design of antineoplastic agents using 3D-QSAR, cheminformatic, and virtual screening approaches","volume":"26","author":"Vucicevic","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2022.e10101_bib51","series-title":"2DQSAR, Docking and ADME Studies of PTP1B Inhibitors: A Cure of Diabetes Proceedings of 8th National Level Science Symposium on Recent Trends in Science and Technology","author":"Vyas","year":"2015"},{"issue":"11","key":"10.1016\/j.heliyon.2022.e10101_bib52","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3390\/ijms19113423","article-title":"Prediction of the toxicity of binary mixtures by QSAR approach using the hypothetical descriptors","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10101_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/cbdd.12942","article-title":"Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents","volume":"90","author":"Wang","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.heliyon.2022.e10101_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113161","article-title":"Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors","volume":"213","author":"Xiao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"W1","key":"10.1016\/j.heliyon.2022.e10101_bib55","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2022.e10101_bib56","series-title":"Deep Neural Networks for QSAR, Artificial Intelligence in Drug Design","first-page":"233","author":"Xu","year":"2022"}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2023.e18877","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"record-id":"47145"},{"DOI":"10.1016\/j.heliyon.2022.e10101","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000}},{"DOI":"10.1016\/j.heliyon.2023.e18877","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022013895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022013895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:15:38Z","timestamp":1772010938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022013895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2405844022013895"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10101","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"e10101"}}